Opportunity Information: Apply for RFA HL 12 005
Apply for RFA HL 12 005
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Clinical Hematology and Transfusion Medicine Research Career Development Program (K12)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.839 Blood Diseases and Resources Research.
- This funding opportunity was created on Apr 14, 2011 and posted on Apr 14, 2011.
- Applicants must submit their applications by Jun 20, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $13,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $370,000.00 in funding.
- Eligible applicants include: Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non U.S.) components of U.S. Organizations are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Clinical Hematology and Transfusion Medicine Research Career Development Program (K12) is a National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) funding opportunity designed to help institutions build structured, multidisciplinary career development programs for early stage clinical researchers working in non-malignant hematology and transfusion medicine. The central goal is to create an organized pathway that prepares new investigators to tackle complicated, real-world problems in blood disorders and transfusion practice, and to position them to become independent investigators and future academic leaders in these areas. Rather than supporting a single research project, this K12 mechanism supports an institutional training environment that develops multiple scholars through a coordinated program of education, mentorship, and hands-on research experience focused specifically on non-cancer blood diseases and transfusion medicine across diverse patient populations.
A key emphasis of the program is comprehensive training that blends clinical domain expertise with strong clinical research skills. Funded programs are expected to provide a structured core curriculum and didactic teaching that covers research designs and methodologies used in clinical investigation, along with exposure to both established standards of care and emerging or innovative approaches to managing patients with non-malignant hematologic conditions. The training environment is expected to be multidisciplinary, reflecting the reality that advances in transfusion medicine and hematology often require collaboration across specialties such as internal medicine, pediatrics, pathology/transfusion services, epidemiology, biostatistics, and related fields. In addition to coursework and seminars, each supported Scholar must complete a short-term research project, ensuring that participants gain practical experience developing questions, designing studies, working with clinical data or patient populations, and translating findings into future independent research directions.
This opportunity (Funding Opportunity Number RFA-HL-12-005) is a discretionary grant using the NIH K12 institutional career development mechanism, under the health funding activity category tied to CFDA 93.839 (Blood Diseases and Resources Research). The FOA was posted April 14, 2011, with an original and current closing date of June 20, 2011, and it was archived July 21, 2011. NHLBI estimated total funding for the initiative at $13.5 million, with an award ceiling of $370,000, and there is no cost-sharing or matching requirement stated for applicants. In practical terms, these figures indicate NHLBI intended to fund multiple institutional programs nationally, each receiving up to the stated cap to run a scholar-focused career development structure rather than a single-investigator grant.
Eligibility is broad across U.S.-based organizations capable of hosting strong clinical research training environments. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status, as specified), and certain tribal and community-based entities. The eligibility listing explicitly includes organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, U.S. territories or possessions, and Native American tribal governments (federally recognized and other than federally recognized, as described). Non-U.S. (foreign) organizations are not eligible to apply as the applicant institution; however, foreign components of U.S. organizations are allowed, which can be important for programs that include international collaborations or specialized training experiences linked to a U.S. applicant institution.
Operationally, NHLBI is inviting institutions with established clinical research infrastructure and demonstrated expertise in non-malignant clinical hematology and transfusion medicine. That requirement signals that successful applicants should already have the patient populations, clinical services (including transfusion medicine capabilities), mentorship depth, and research support systems needed to offer meaningful scholar experiences. The expectation is that scholars emerge from these programs with a durable foundation in clinical investigation, real exposure to modern hematology and transfusion practice questions, and a clear trajectory toward independent funding and leadership roles in academia. For full details, the announcement was made available through NIH at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-005.html, with technical access issues directed to the NIH Office of Extramural Research (OER) webmaster contact listed in the posting.
Frequently Asked Questions (FAQs)
What is the Clinical Hematology and Transfusion Medicine Research Career Development Program (K12)?
It is an NIH National Heart, Lung, and Blood Institute (NHLBI) funding opportunity that supports institutions in building structured, multidisciplinary career development programs for early stage clinical researchers in non-malignant hematology and transfusion medicine.
What is the central goal of this K12 program?
The goal is to create an organized pathway that prepares new investigators to tackle real-world problems in blood disorders and transfusion practice, and to position them to become independent investigators and future academic leaders in non-malignant hematology and transfusion medicine.
Does this opportunity fund a single research project or a training program?
This K12 mechanism supports an institutional training environment rather than a single research project. It is designed to develop multiple scholars through a coordinated program of education, mentorship, and hands-on research experience.
What scientific and clinical areas are emphasized?
The focus is on non-malignant (non-cancer) hematology and transfusion medicine, including research and practice questions in blood disorders and transfusion across diverse patient populations.
Who is the intended trainee audience?
The program is intended for early stage clinical researchers (referred to as Scholars) pursuing career development in non-malignant clinical hematology and transfusion medicine.
What kinds of training elements are expected in funded programs?
Funded programs are expected to provide a structured core curriculum and didactic teaching covering clinical research designs and methodologies, along with exposure to standards of care and emerging or innovative approaches in managing non-malignant hematologic conditions.
Is hands-on research required for each Scholar?
Yes. Each supported Scholar must complete a short-term research project to gain practical experience developing research questions, designing studies, working with clinical data or patient populations, and translating findings into future independent research directions.
What does "multidisciplinary" mean in the context of this program?
The training environment is expected to reflect collaboration across specialties commonly involved in hematology and transfusion advances, such as internal medicine, pediatrics, pathology/transfusion services, epidemiology, biostatistics, and related fields.
Which NIH institute is sponsoring this opportunity?
The opportunity is sponsored by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH).
What is the Funding Opportunity Number (FOA number)?
RFA-HL-12-005.
What grant mechanism is used for this program?
It uses the NIH K12 institutional career development mechanism and is described as a discretionary grant.
What is the CFDA number and program area associated with this opportunity?
CFDA 93.839, Blood Diseases and Resources Research.
When was the FOA posted, and what were the closing dates?
The FOA was posted on April 14, 2011. The original and current closing date listed is June 20, 2011.
Is this funding opportunity still active?
No. The announcement was archived on July 21, 2011, and the closing date listed is June 20, 2011.
How much total funding did NHLBI estimate for this initiative?
NHLBI estimated total funding at $13.5 million.
What is the award ceiling?
The award ceiling listed is $370,000.
Is cost sharing or matching required?
No cost-sharing or matching requirement is stated for applicants.
Who is eligible to apply as the applicant organization?
Eligible applicants include U.S.-based organizations capable of hosting strong clinical research training environments, including public and state-controlled institutions of higher education, private institutions of higher education, and nonprofit organizations (including those with and without 501(c)(3) status, as specified).
Are minority-serving institutions and tribal entities included in the eligibility listing?
Yes. The eligibility listing explicitly includes organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, U.S. territories or possessions, and Native American tribal governments (federally recognized and other than federally recognized, as described).
Can a non-U.S. (foreign) organization apply as the applicant institution?
No. Non-U.S. (foreign) organizations are not eligible to apply as the applicant institution.
Are foreign components allowed under a U.S. applicant organization?
Yes. Foreign components of U.S. organizations are allowed, which may support international collaborations or specialized training experiences connected to the U.S. applicant institution.
What kind of institutional environment is NHLBI looking for?
NHLBI is inviting institutions with established clinical research infrastructure and demonstrated expertise in non-malignant clinical hematology and transfusion medicine, including the patient populations, clinical services (including transfusion medicine capabilities), mentorship depth, and research support systems needed for meaningful scholar experiences.
What outcomes are expected for Scholars completing the program?
Scholars are expected to emerge with a durable foundation in clinical investigation, real exposure to modern hematology and transfusion practice questions, and a clear trajectory toward independent funding and leadership roles in academia.
Where can applicants find the official NIH announcement text?
The announcement is available through NIH at http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-12-005.html.
Who should be contacted for technical access issues with the FOA web posting?
Technical access issues are directed to the NIH Office of Extramural Research (OER) webmaster contact listed in the posting.
Browse more opportunities from the same category: Health
Next opportunity: NCSE Task for NPS Wilderness Intern
Previous opportunity: Electronic Photonic Heterogeneous Integration (E PHI)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA HL 12 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA HL 12 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition for Continuation of Induced Pluripotent Stem Cell (iPSC) Resources promoting Translational Research Advancements in Neurodegenerative Diseases (U24) Apply for RFA NS 11 011 Funding Number: RFA NS 11 011 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Strenghtening HIV Prevention Services for Most at Risk Popluations Apply for RFA 620 11 000001 Funding Number: RFA 620 11 000001 Agency: Agency for International Development Category: Health Funding Amount: $50,000,000 |
| Cooperative Agreement for the Historically Black Colleges and Universities Center for Excellence in Behavioral Health Apply for TI 11 013 Funding Number: TI 11 013 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $500,000 |
| Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers Apply for CMS 1A1 11 001 Funding Number: CMS 1A1 11 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $3,000,000 |
| Early Phase Clinical Trials for Blood Cell Therapies (R01) Apply for PAR 11 204 Funding Number: PAR 11 204 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Public Health Emergency Preparedness Cooperative Agreement Apply for CDC RFA TP11 1101 Funding Number: CDC RFA TP11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for the Cardiovascular Cell Therapy Research Network (CCTRN) (UM1) Apply for RFA HL 12 025 Funding Number: RFA HL 12 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regional Clinical Centers for the Cardiovascular Cell Therapy Research Network (CCTRN) (UM1) Apply for RFA HL 12 026 Funding Number: RFA HL 12 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Beyond HAART Innovative Therapies to Control HIV 1 (P01) Apply for RFA AI 11 012 Funding Number: RFA AI 11 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Education Project Grants (R25) Apply for PAR 11 205 Funding Number: PAR 11 205 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Poison Center Support and Enhancement Grant Program Apply for HRSA 11 133 Funding Number: HRSA 11 133 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Planning and Management of a Public Health Communication and Community Engagement Technical Assistance Cooperative Agreement Apply for CDC RFA CD11 1101 Funding Number: CDC RFA CD11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $750,000 |
| Area Health Education Centers Infrastructure Development Apply for HRSA 11 033 Funding Number: HRSA 11 033 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Area Health Education Centers Point of Service Maintenance and Enhancement Apply for HRSA 11 034 Funding Number: HRSA 11 034 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| RG 04222011 Opp1 title Apply for RG 04222011 OPP1 Funding Number: RG 04222011 OPP1 Agency: IVV Test Agency Category: Health Funding Amount: Case Dependent |
| RG 04222011 Opp2 title Apply for RG 04222011 OPP2 Funding Number: RG 04222011 OPP2 Agency: IVV Test Agency Category: Health Funding Amount: Case Dependent |
| PPHF 2012 Community Transformation Grants Applied Public Health Leadership Training Program financed solely by 2012 Prevention and Public Health Funds Apply for CDC RFA OT11 1101 Funding Number: CDC RFA OT11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Public Health Support for Land Reuse/Brownfield and Legacy Sites in the Areas of Concern (AOC) for the Great Lakes Apply for CDC RFA TS11 1104 Funding Number: CDC RFA TS11 1104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $280,000 |
| Community Health Projects Related to Contamination at Land Reuse and Brownfield Sites Apply for CDC RFA TS11 1103 Funding Number: CDC RFA TS11 1103 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Partnership for Surveillance Collaborative Apply for CDC RFA OE11 1104 Funding Number: CDC RFA OE11 1104 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA HL 12 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.